Anacor Pharmaceuticals - Barchart's Chart of the day

Anacor Pharmaceuticals (ANAC) is the Barchart Chart of the Day.  The stock has a Trend Spotter buy signal, a Weighted Alpha of 184.50+ and gained 132.28% in the last year.


The Chart of the Day belongs to Anacor Pharmaceuticals (ANAC). I found the pharmaceutical stock by sorting the All Time High list for the best technical buy signals, then used the Trend Spotter to review the charts.  Since the Trend Spotter signaled a buy on 1/20 the stock gained 42.65%.

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform. Its three lead product candidates include two topically administered dermatologic compounds-AN2690, an antifungal for the treatment of onychomycosis, and AN2728, an anti-inflammatory for the treatment of psoriasis, as well as a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria-GSK2251052. Additionally, the Company also develops topical antifungal product for the treatment of onychomycosis and skin fungal infections, topical anti-inflammatory product for the treatment of psoriasis and atopic dermatitis.

Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

• 100% Barchart technical buy signals
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 13 new highs and up 32.19% in the last month
• Relative Strength Index 84.21%
• Barchart computes a technical support level at 45.06
• Recently traded at 49.10 with a 50 day moving average of 37.10

Fundamental factors:

• Market Cap $2.06 billion
• Revenue expected to grow by 16.70% next year
• Earnings estimated to increase 25.00% next year
• Wall Street analysts issued 3 strong buy, 1 buy and 1 hold recommendation on the stock

Thew 20-100 Day MACD Oscillator has works as an extremely good technical trading strategy on this stock and should continue to be used for entry and exit points.